Gilead Sciences Inc
NASDAQ:GILD
Gilead Sciences Inc
NASDAQ:GILD
Price:
64.7 USD
1.33%
Market Closed
Updated:
Jun 10, 2024
Gilead Sciences Inc
Cash Paid for Dividends
|
Gilead Sciences Inc
Cash Paid for Dividends Peer Comparison
Comparables:
ABBV
AMGN
MRNA
VRTX
REGN
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Paid for Dividends
-$3.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Paid for Dividends
-$10.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-15%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Paid for Dividends
-$4.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-12%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gilead Sciences Inc's Cash Paid for Dividends?
Cash Paid for Dividends
-3.8B
USD
-3.8B
USD
Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Cash Paid for Dividends amounts to -3.8B USD.
What is Gilead Sciences Inc's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 5Y
-5%
-5%
Over the last year, the Cash Paid for Dividends growth was -3%. The average annual Cash Paid for Dividends growth rates for Gilead Sciences Inc have been -3% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
